arrow
A

Aaron Prendergast

queen mary university london
H指数:16
被引数:2,082

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (vol 25, pg 1706, 2019)
2023-03-210
OA
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
2022-08-0182
OA
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

接受根治性膀胱切除术的肌层浸润性膀胱癌患者新辅助阿特珠单抗的毒性和手术并发症发生率: ABACUS试验的最新安全性结果

2021-06-0123
PRE
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

将全反式维甲酸重新用作胰腺癌基质靶向剂的I期临床试验

2020-09-24145
OAAI
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (vol 25, pg 1706, 2019)
2020-05-151
OAAI
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

ABACUS试验中阿特珠单抗新辅助治疗可手术尿路上皮癌的临床疗效和生物标志物分析

2019-11-04415
OAAI
Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
2019-01-0123
OA